Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathies, The Lancet, vol.364, issue.9441, pp.1252-1259, 2004. ,
DOI : 10.1016/S0140-6736(04)17142-0
The Molecular Basis of Goodpasture and Alport Syndromes: Beacons for the Discovery of the Collagen IV Family, Journal of the American Society of Nephrology, vol.15, issue.10, pp.2514-2527, 2004. ,
DOI : 10.1097/01.ASN.0000141462.00630.76
RECURRENCE OF NEPHROTIC SYNDROME IN KIDNEY GRAFTS OF PATIENTS WITH CONGENITAL NEPHROTIC SYNDROME OF THE FINNISH TYPE, Transplantation, vol.73, issue.3, pp.394-403, 2002. ,
DOI : 10.1097/00007890-200202150-00013
Immunologic considerations for enzyme replacement therapy in the treatment of lysosomal storage disorders, Clinical and Applied Immunology Reviews, vol.2, issue.4-5, pp.241-253, 2002. ,
DOI : 10.1016/S1529-1049(02)00049-1
Immune Response to Enzyme Replacement Therapy in Lysosomal Storage Disorder Patients and Animal Models, Molecular Genetics and Metabolism, vol.68, issue.2, pp.268-275, 1999. ,
DOI : 10.1006/mgme.1999.2894
Immune Responses to Therapeutic Proteins in Humans - Clinical Significance, Assessment and Prediction, Current Pharmaceutical Biotechnology, vol.3, issue.4, pp.349-360, 2002. ,
DOI : 10.2174/1389201023378175
Nephrotic Syndrome Complicating ??-Glucosidase Replacement Therapy for Pompe Disease, PEDIATRICS, vol.114, issue.4, pp.532-535, 2004. ,
DOI : 10.1542/peds.2003-0988-L
The molecular basis of lysosomal storage diseases and their treatment, Biochemical Society Transactions, vol.28, issue.2, pp.150-154, 2000. ,
DOI : 10.1042/bst0280150
EXPERIMENTAL GLOMERULONEPHRITIS: THE PATHOGENESIS OF A LABORATORY MODEL RESEMBLING THE SPECTRUM OF HUMAN GLOMERULONEPHRITIS, Journal of Experimental Medicine, vol.113, issue.5, pp.899-920, 1961. ,
DOI : 10.1084/jem.113.5.899
Human Idiopathic Membranous Nephropathy ??? A Mystery Solved?, New England Journal of Medicine, vol.361, issue.1, pp.81-83, 2009. ,
DOI : 10.1056/NEJMe0903343
Pathogenesis of membranous nephropathy: recent advances and future challenges, Nature Reviews Nephrology, vol.181, issue.4, pp.203-213 ,
DOI : 10.1007/s00467-006-0203-6
URL : https://hal.archives-ouvertes.fr/inserm-00919135
Receptor as Target Antigen in Idiopathic Membranous Nephropathy, New England Journal of Medicine, vol.361, issue.1, pp.11-21, 2009. ,
DOI : 10.1056/NEJMoa0810457
URL : https://hal.archives-ouvertes.fr/hal-00417718
Early-Childhood Membranous Nephropathy Due to Cationic Bovine Serum Albumin, New England Journal of Medicine, vol.364, issue.22, pp.2101-2110, 2011. ,
DOI : 10.1056/NEJMoa1013792
Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study, The Journal of Pediatrics, vol.148, issue.4, pp.533-539, 2006. ,
DOI : 10.1016/j.jpeds.2005.12.014
Design, baseline characteristics, and early findings of the MPS VI (mucopolysaccharidosis VI) Clinical Surveillance Program (CSP), Journal of Inherited Metabolic Disease, vol.10, issue.Suppl 1, pp.373-384, 2013. ,
DOI : 10.1007/s10545-011-9410-9
Podocyte Glutamatergic Signaling Contributes to the Function of the Glomerular Filtration Barrier, Journal of the American Society of Nephrology, vol.20, issue.9, pp.1929-1940, 2009. ,
DOI : 10.1681/ASN.2008121286
Inhibition of the human intermediate conductance Ca2+-activated K+ channel, hIK1, by volatile anesthetics, European Journal of Pharmacology, vol.395, issue.2, pp.95-101, 2000. ,
DOI : 10.1016/S0014-2999(00)00254-5
Human Podocytes Possess a Stretch-Sensitive, Ca2+-Activated K+ Channel: Potential Implications for the Control of Glomerular Filtration, Journal of the American Society of Nephrology, vol.15, issue.12, pp.2981-2987, 2004. ,
DOI : 10.1097/01.ASN.0000145046.24268.0D
Chinese hamster ovary cell-derived recombinant human acid ??-glucosidase in infantile-onset Pompe disease, The Journal of Pediatrics, vol.149, issue.1, pp.89-97, 2006. ,
DOI : 10.1016/j.jpeds.2006.02.035
Immunosurveillance of alglucerase enzyme therapy for Gaucher patients: Induction of humoral tolerance in seroconverted patients after repeat administration, Blood, vol.93, pp.2081-2088, 1999. ,
Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatment, Nature Biotechnology, vol.268, issue.8, pp.901-908, 2008. ,
DOI : 10.1080/080352502760148621
Recurrent Membranous Nephropathy in an Allograft Caused by IgG3?? Targeting the PLA2 Receptor, Journal of the American Society of Nephrology, vol.23, issue.12, pp.1949-1954 ,
DOI : 10.1681/ASN.2012060577
URL : https://hal.archives-ouvertes.fr/inserm-00919065